Tuesday, March 28, 2017 3:12:32 PM
A new report by New Frontier Data estimates that the legal cannabis market was worth $6.6 billion in 2016 and is projected to grow at a compound annual growth rate (CAGR) of 16%, or reaching more than $24 billion by 2025. As more states have legalized medical cannabis as oppose to recreational, the medical market is projected to grow at 12% CAGR through 2025, or growing from $4.7 billion in 2016 to an estimated $13.3 billion in 2025. States where sales of cannabis products are legal, anticipate generating significant tax revenues as a result. 22nd Century Group Inc. (NYSE: XXII), Axim Biotechnologies Inc. (OTC: AXIM), GW Pharmaceuticals (NASDAQ: GWPH), Zynerba Pharmaceuticals Inc. (NASDAQ: ZYNE), Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP)
Source: Full Article
Tags: Including $HADV $GWPH $TWMJF $APHQF $ACBFF $AXIM $CRBP $MJNA
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM